| Successful use of extracorporeal membrane oxygenation in a hematopoietic stem cell transplant patient with idiopathic pneumonia syndrome. | |
| | |
MedLine Citation:
|
PMID: 23359731 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
We report the case of an adult patient with idiopathic pneumonia syndrome following allogeneic hematopoietic stem cell transplantation, which was successfully managed with venovenous extracorporeal membrane oxygenation (ECMO) and immunosuppressive therapy. A 30-year-old man with precursor B cell acute lymphocytic leukemia had received chemotherapy 10 years previously, with complete remission. He underwent allogeneic hematopoietic stem cell transplantation 4 months prior to enrollment, owing to leukemia relapse. One hundred thirty days post-transplant the patient developed shortness of breath, nonproductive cough, and low-grade fever for 1 week. He subsequently developed acute hypercapnic and hypoxic respiratory failure that was unresponsive to conventional medical therapy. He was successfully managed with venovenous ECMO for 19 days, with complete resolution of his respiratory symptoms. Thus, judicious use of ECMO as a bridge before steroid and other conventional therapy take effect in patients with isolated respiratory failure appears justified. |
| | |
Authors:
|
Wen-I Liao; Shih-Hung Tsai; Sheng-Kang Chiu |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Respiratory care Volume: 58 ISSN: 0020-1324 ISO Abbreviation: Respir Care Publication Date: 2013 Feb |
Date Detail:
|
Created Date: 2013-01-29 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7510357 Medline TA: Respir Care Country: United States |
Other Details:
|
Languages: eng Pagination: e6-e10 Citation Subset: IM |
Affiliation:
|
Department of Emergency Medicine. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: AARC Clinical Practice Guideline. Surfactant Replacement Therapy: 2013.
Next Document: Could energy-intensive industries be powered by carbon-free electricity?